Contract 75A50124C00027
Revvity Health Sciences, Inc. · Department Of Health And Human Services · September 27, 2024
Revvity Health Sciences, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 27, 2024 for $9.26 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Hopkinton, MA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses cost no fee contract pricing. The most recent modification was on September 30, 2024.
Contract details
- PIID
- 75A50124C00027
- Award type
- Definitive Contract
- Pricing
- Cost No Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- Place of performance
- Hopkinton, MA
- First action
- September 27, 2024
- Latest action
- September 30, 2024
Description
MULTIPLEX, ACCURATE, RAPID, TESTING FOR YOU (MARTY)
Modification timeline
-
September 30, 2024Mod P00001 · Other Administrative Action$9.26M
-
September 27, 2024Base award$9.26M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50124C00027?
Contract 75A50124C00027 is a federal contract awarded to Revvity Health Sciences, Inc. by Department Of Health And Human Services on September 27, 2024 for $9.26 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75A50124C00027?
Revvity Health Sciences, Inc. won contract 75A50124C00027 from Department Of Health And Human Services.
How much is contract 75A50124C00027 worth?
Contract 75A50124C00027 has obligated $9.26 million to date.